サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1514975

スルホンアミド市場：投与経路別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測

Sulphonamides Market, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 263 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.87円
スルホンアミド市場：投与経路別、用途別、エンドユーザー別、国別、地域別-2024～2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年06月04日
発行: AnalystView Market Insights
ページ情報: 英文 263 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

スルホンアミド市場規模は2023年に1億2,940万米ドルとなり、2024～2032年にかけてCAGR 4.50%で拡大

スルホンアミド市場-市場力学

感染症の流行、慢性疾患の増加、併用療法への高い需要が市場需要を促進すると予測

感染症が引き続き世界の健康上の大きな課題となっていることから、スルホンアミドのような効果的な抗生物質に対する需要が大幅に増加しています。尿路感染症、呼吸器感染症、性感染症などの細菌感染症の増加が、スルホンアミド系を含む抗生物質の必要性を高めています。スルホンアミドは、関節リウマチ（スルファサラジンなど）や炎症性腸疾患などの慢性疾患の治療にも使用されています。これらの疾患の蔓延は、スルホンアミド成分を含む医薬品に対する継続的な需要の原動力となっています。

スルホンアミドは、しばしばトリメトプリムやコトリモキサゾールなどの他の抗生物質と併用され、有効性を高め、耐性菌に対抗しています。このような併用療法の開発と使用は、臨床現場におけるスルホンアミドの需要に寄与しています。スルホンアミドは新しい抗生物質と比較してより安価です。この費用対効果は、資源が限られている医療システムにおいて特に重要であり、このような抗生物質でも効果的な治療選択肢を提供することができます。これらの要因が市場の成長を後押しすると期待されています。

スルホンアミド市場-主要洞察

当社のリサーチアナリストの分析によると、世界市場は予測期間（2024～2032年）に約4.50%のCAGRで毎年成長すると推定されています。

投与経路別では、経口薬セグメントは、最近のCOVID-19の危機と治療により、2023年に最大の市場シェアを示すと予測されました。

用途別セグメントでは、尿路感染症（UTI）セグメントが2023年の主要用途でした。

エンドユーザー別では、泌尿器、糖尿病、その他の慢性疾患の治療に対する高いニーズにより、病院セグメントが2023年の主要エンドユーザーでした。

地域別では、慢性疾患の有病率の高さから、北米が2023年の売上高をリードしています。

スルホンアミド市場-セグメンテーション分析：

スルホンアミドの世界市場は、投与経路、用途、エンドユーザー、地域に基づいて区分されます。

市場は投与経路によって経口剤、外用剤、その他の3つに分類されます。市場を独占しているのは経口剤です。抗生物質と感染症治療への高い需要が市場成長を補完しています。

用途別では、皮膚感染症、尿路感染症（UTI）、呼吸器感染症（RTI）、消化管感染症（GIT）、その他の5つに分類されます。PCR法セグメントが市場を独占しています。泌尿器関連疾患の増加と尿路結石に関する新たな研究が、このセグメントの需要に寄与しています。

市場はエンドユーザー別に病院、クリニック、その他の3つに分類されます。病院セグメントが市場を独占しており、予測期間中も高い優位性を維持すると予想されます。技術の進歩や皮膚、腎臓感染症の治療が主に市場の成長を後押ししています。

スルホンアミド市場-地理的洞察

スルホンアミド市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域で広く普及しています。北米、西欧、アジア太平洋（日本、オーストラリアなど）は、医療システムがしっかりしている先進地域であり、スルホンアミドの消費量が多いです。これは医療施設へのアクセスが良いためです。ラテンアメリカ、東欧、アジア太平洋（インド、中国など）、アフリカの国々では、医療費の増加と医療インフラの改善が進んでいます。

スルホンアミド市場-競合情勢：

スルホンアミド市場の競争は中程度です。各社はそれぞれの地域の市場環境、規制環境、医療制度に合わせて戦略を立てています。老舗企業は多くの場合、複数の国にまたがる販売網を持つ世界の存在感を示しています。製造プロセスや技術の進歩は、競争上の位置付けにおいて重要な役割を果たしています。製造や製剤強化のために新技術を採用し統合する企業は、効率と製品品質を向上させることができます。さらに、スルホンアミド医薬品の新しい製剤を開発し、有効性を向上させ、副作用を軽減するために、競合企業は研究開発に多額の投資を行っています。このような継続的な研究が、市場における技術革新と差別化の原動力となっています。

目次

第1章 スルホンアミド市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブ概要

  • 市場内訳
  • 競合考察

第3章 スルホンアミドの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 スルホンアミド産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長展望マッピング
  • 規制枠組み分析

第5章 スルホンアミド市場： COVID-19の影響分析

  • COVID-19前の影響分析
  • COVID-19後の影響分析

第6章 スルホンアミド市場情勢

  • スルホンアミド市場シェア分析、2024年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 スルホンアミド市場-投与経路別

  • 概要
    • 投与経路別セグメントシェア分析
    • 経口薬
    • 外用薬
    • その他

第8章 スルホンアミド市場-用途別

  • 概要
    • 用途別セグメントシェア分析
    • 皮膚感染症
    • 尿路感染症（UTI）
    • 呼吸器感染症（RTI）
    • 胃腸管（GIT）
    • その他

第9章 スルホンアミド市場-エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • クリニック
    • その他

第10章 スルホンアミド市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-スルホンアミド業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Merck &Co., Inc.
    • Bayer AG
    • Johnson &Johnson
    • Abbott Laboratories
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Valeo Pharma Inc.
    • Eli Lilly and Company
    • Boehringer Ingelheim International GmbH
    • Mylan NV
    • その他

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sulphonamides Market: Route of Administration Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Sulphonamides Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Sulphonamides Market, by Application 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Sulphonamides Market, by End User 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sulphonamides Market, by Region 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Sulphonamides Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Route of Administration segment market share analysis, 2024 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Sulphonamides Market share and leading players, 2024
  • FIGURE Europe Sulphonamides Market share and leading players, 2024
  • FIGURE Asia Pacific Sulphonamides Market share and leading players, 2024
  • FIGURE Latin America Sulphonamides Market share and leading players, 2024
  • FIGURE Middle East and Africa Sulphonamides Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Sulphonamides Market share analysis by country, 2024
  • FIGURE Germany Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Sulphonamides Market share analysis by country, 2024
  • FIGURE India Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market share analysis by country, 2024
  • FIGURE Brazil Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market share analysis by country, 2024
  • FIGURE Saudi Arabia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3081

REPORT HIGHLIGHT

Sulphonamides Market size was valued at USD 129.40 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

Sulphonamides, also known as sulfonamides, are a class of synthetic antimicrobial agents that work by inhibiting bacterial growth. Sulphonamides is used to treat a range of infections, including urinary tract infections, respiratory tract infections, bacterial meningitis, and some sexually transmitted infections. They are also sometimes used in combination with other antibiotics for synergistic effects.

Sulphonamides Market- Market Dynamics

Growing prevalence of infection, chronic diseases and high demand for combinational therapies are expected to propel market demand

As infectious diseases continue to pose significant global health challenges, the demand for effective antibiotics like sulphonamides is rising significantly. The rise in bacterial infections such as urinary tract infections, respiratory infections, and sexually transmitted diseases drives the need for antibiotics, including sulphonamides. Sulphonamides are also used in the treatment of chronic conditions such as rheumatoid arthritis (e.g., sulfasalazine) and inflammatory bowel disease. The prevalence of these conditions drives ongoing demand for medications containing sulphonamide components.

Sulphonamides are often used in combination with other antibiotics like trimethoprim e.g., co-trimoxazole to enhance efficacy and combat resistance. The development and use of such combination therapies contribute to the demand for sulphonamides in clinical practice. Sulphonamides are more affordable compared to newer antibiotics. This cost-effectiveness is particularly important in healthcare systems with limited resources, where these antibiotics can still provide effective treatment options. These factors are expected to bolster market growth.

Sulphonamides Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)

Based on Route of Administration segmentation, the oral segment was predicted to show maximum market share in the year 2023, owing to the recent COVID-19 crisis & cure.

Based on Application segmentation, the urinary tract infection (UTI) segment was the leading Application in 2023, owing to rising bacterial infection that causes mortality also.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high need for treatment of urinary, diabetic, and other chronic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of chronic diseases.

Sulphonamides Market- Segmentation Analysis:

The Global Sulphonamides Market is segmented on the basis of Route of Administration, Application, End User, and Region.

The market is divided into three categories based on the Route of Administration: oral, topical, and others. The oral segment dominates the market. The high demand for antibiotics and infectious disease treatment is supplementing the market growth.

The market is divided into five categories based on the Application: skin infection, urinary tract infection (UTI), respiratory tract infection (RTI), gastrointestinal tract (GIT), and others. The PCR-based method segment dominates the market. Rising urinary-related diseases and new research in UTIs is contributing to segment demand.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The advancement in technologies and treatment of skin, and kidney transmitted disorders are mainly boosting the market growth.

Sulphonamides Market- Geographical Insights

Worldwide, the Sulphonamides market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed regions with robust healthcare systems, such as North America, Western Europe, and parts of Asia-Pacific including Japan, Australia, etc. often have higher consumption of sulphonamides. This is due to better access to healthcare facilities. Countries in Latin America, Eastern Europe, Asia-Pacific (e.g., India, China), and Africa are experiencing increasing healthcare expenditure and improving healthcare infrastructure.

Sulphonamides Market- Competitive Landscape:

The Sulphonamides market is moderately competitive. Companies adapt their strategies to local market conditions, regulatory environments, and healthcare systems. Established players often have a global presence with distribution networks spanning multiple countries. Advances in manufacturing processes and technologies play a significant role in competitive positioning. Companies that adopt and integrate new technologies for production or formulation enhancement can improve efficiency and product quality. Further, competing companies invest heavily in R&D to develop new formulations, improve efficacy, and reduce the side effects of sulphonamide drugs. This ongoing research drives innovation and differentiation in the market.

Recent Developments:

In August 2022, Valeo Pharma Inc. formed a supply and commercialization agreement with Novartis Pharmaceuticals in Canada for the commercialization of SIMBRINZA.

In July 2022, Azurity Pharmaceuticals Inc. established endorsement from the US FDA for ZONISADE.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SULPHONAMIDES MARKET KEY PLAYERS

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson
  • Abbott Laboratories
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company
  • Valeo Pharma Inc.
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Mylan N.V.
  • Others

GLOBAL SULPHONAMIDES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032

  • Oral
  • Topical
  • Others

GLOBAL SULPHONAMIDES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Skin infection
  • Urinary Tract Infection (UTI)
  • Respiratory Tract Infection (RTI)
  • Gastro-Intestinal Tract (GIT)
  • Others

GLOBAL SULPHONAMIDES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL SULPHONAMIDES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sulphonamides Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sulphonamides Market Snippet by Route of Administration
    • 2.1.2. Sulphonamides Market Snippet by Application
    • 2.1.3. Sulphonamides Market Snippet by End User
    • 2.1.4. Sulphonamides Market Snippet by Country
    • 2.1.5. Sulphonamides Market Snippet by Region
  • 2.2. Competitive Insights

3. Sulphonamides Key Market Trends

  • 3.1. Sulphonamides Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sulphonamides Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sulphonamides Market Opportunities
  • 3.4. Sulphonamides Market Future Trends

4. Sulphonamides Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sulphonamides Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sulphonamides Market Landscape

  • 6.1. Sulphonamides Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sulphonamides Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Topical
    • 7.1.4. Others

8. Sulphonamides Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Skin infection
    • 8.1.3. Urinary Tract Infection (UTI)
    • 8.1.4. Respiratory Tract Infection (RTI)
    • 8.1.5. Gastro-Intestinal Tract (GIT)
    • 8.1.6. Others

9. Sulphonamides Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Sulphonamides Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sulphonamides Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sulphonamides Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sulphonamides Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sulphonamides Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sulphonamides Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sulphonamides Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis AG
    • 11.2.4. Sanofi S.A.
    • 11.2.5. F. Hoffmann-La Roche Ltd
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Bayer AG
    • 11.2.8. Johnson & Johnson
    • 11.2.9. Abbott Laboratories
    • 11.2.10. AstraZeneca PLC
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Bristol-Myers Squibb Company
    • 11.2.13. Valeo Pharma Inc.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Boehringer Ingelheim International GmbH
    • 11.2.16. Mylan N.V.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us